Title: Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
Authors: Ratner, R E ×
Gough, S C L
Mathieu, Chantal
Del Prato, S
Bode, B
Mersebach, H
Endahl, L
Zinman, B #
Issue Date: Feb-2013
Publisher: Blackwell Science
Series Title: Diabetes, Obesity & Metabolism vol:15 issue:2 pages:175-84
Article number: 10.1111/dom.12032
Abstract: Hypoglycaemia and the fear of hypoglycaemia are barriers to achieving normoglycaemia with insulin. Insulin degludec (IDeg) has an ultra-long and stable glucose-lowering effect, with low day-to-day variability. This pre-planned meta-analysis aimed to demonstrate the superiority of IDeg over insulin glargine (IGlar) in terms of fewer hypoglycaemic episodes at equivalent HbA1c in type 2 and type 1 diabetes mellitus (T2DM/T1DM).
ISSN: 1462-8902
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Clinical and Experimental Endocrinology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science